HSV-1 Amplicon vectors as genetic vaccines

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

HSV-1 amplicon vectors have been used as platforms for the generation of genetic vaccines against both DNA and RNA viruses. Mice vaccinated with such vectors encoding structural proteins from both footand- mouth disease virus and rotavirus were partially protected from challenge with wild-type virus (D’Antuono et al. Vaccine 28: 7363–7372, 2010; Laimbacher et al. Mol Ther 20: 1810–1820, 2012), indicating that HSV-1 amplicon vectors are attractive tools for the development of complex and safe genetic vaccines. This chapter describes the use of HSV-1 amplicon vectors that encode individual or multiple viral structural proteins from a polycistronic transgene cassette in mammalian cells. More precisely, amplicon vectors that encode multiple structural viral proteins support the in situ production of viruslike particles (VLPs) in vector-infected cells. The expression of the viral genes is confi rmed by Western blot and immune fl uorescence analysis, and the generation of VLPs in vector-infected cells is demonstrated by electron microscopy.

Cite

CITATION STYLE

APA

Laimbacher, A. S., & Fraefel, C. (2014). HSV-1 Amplicon vectors as genetic vaccines. Methods in Molecular Biology, 1144, 99–115. https://doi.org/10.1007/978-1-4939-0428-0_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free